For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Advocate slams ‘knee-jerk’ Whaikaha budget criticism
Wednesday 11 September 2024, 03:00 AM

Tania Kingi, chief executive of disability advocacy agency Te Roopu Waiora [Image: Supplied]
Reporter Zach Thompson follows up the recent review looking at funding issues facing Whaikaha – The Ministry of Disabled People and the resulting impact on the sector
ESSENTIALS
The Government is responding to an independent evaluation of Whaikaha and its spending, which found a budget blowout and projected ov, READ MORE
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.